A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application☆,☆☆
The new zoonotic coronavirus (SARS-CoV-2) responsible for coronavirus disease (COVID-19) is a new strain of coronavirus not previously seen in humans and which appears to come from bat species. It originated in Wuhan, Hubei Province, China, and spread rapidly throughout the world, causing over 5,569...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12142
- Acceso en línea:
- https://doi.org/10.1016/j.mehy.2020.109876
http://hdl.handle.net/20.500.12010/12142
- Palabra clave:
- SARS-CoV-2
COVID-19
Viral pneumonia
Aerosol vaporization and nebulization
Alcoholic gargle
Povidone-iodine gargle and eye drop
Remdesivir
IL-1/IL-6
Monoclonal antibody
Cytokine storm
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Acceso restringido